000 03903nam a22005775i 4500
001 978-981-19-8249-1
003 DE-He213
005 20240207153523.0
007 cr nn 008mamaa
008 230301s2023 si | s |||| 0|eng d
020 _a9789811982491
_9978-981-19-8249-1
050 4 _aRM1-950
072 7 _aMMZ
_2bicssc
072 7 _aMJC
_2bicssc
072 7 _aPSY028000
_2bisacsh
072 7 _aMKZ
_2thema
072 7 _aMJC
_2thema
082 0 4 _a615.5
_223
245 1 0 _aProtein-based Therapeutics
_h[electronic resource] /
_cedited by Dev Bukhsh Singh, Timir Tripathi.
250 _a1st ed. 2023.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2023.
300 _aIX, 384 p. 76 illus., 71 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
500 _aAcceso multiusuario
505 0 _aChapter 1_Introduction to Protein Therapeutics. -- Chapter 2_Clinical Applications of Protein-based Therapeutics Against Various Diseases. -- Chapter 3_Protein Engineering Methods for the Design of Protein Therapeutics -- Chapter 4_Recombinant Production of Therapeutic Proteins -- Chapter 5_Antibodies as Protein Therapeutics -- Chapter 6_Streptokinase: The Success Story of a Therapeutic Protein -- Chapter 7_Strategies for Formulation and Systemic Delivery of Therapeutic Proteins -- Chapter 8_Approved Protein Therapeutics and Their Biochemical Targets -- Chapter 9_Pharmacogenetic Biomarkers of Protein Therapeutics -- Chapter 10_Immunogenicity of Therapeutic Proteins -- Chapter 11_Efficacy and Safety Issues of Therapeutic Proteins -- Chapter 12_Emerging Trends, Challenges, and Opportunities in Protein Therapeutics -- Chapter 13_Biosimilar, Biobetter & Biosuperior Therapeutic Proteins -- Chapter 14_Therapeutic Protein-based Vaccines.
520 _a This book provides an overview of the essential characteristics and clinical applications of therapeutic proteins against human diseases, including cancers, immune disorders, infections, and other diseases. It presents the latest advancements in protein engineering techniques for producing desirable therapeutic proteins. The book also covers the strategies used to formulate and deliver systemic therapeutic proteins, approved protein therapeutics and their targets, and pharmacogenetic biomarkers. Further, it discusses challenges associated with the clinical implications of therapeutic proteins, including safety, immunogenicity, protein stability, degradation, and efficacy. It illustrates the development of biosimilar antibodies, optimization strategies for producing biobetter antibodies, and presents fundamental concepts about biosuperior therapeutics. Lastly, it includes a discussion about protein-based vaccines against bacterial and viral infections.
541 _fUABC ;
_cPerpetuidad
650 0 _aTherapeutics.
650 0 _aDiseases.
650 0 _aProteins.
650 1 4 _aTherapeutics.
650 2 4 _aDiseases.
650 2 4 _aProteins.
700 1 _aSingh, Dev Bukhsh.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aTripathi, Timir.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789811982484
776 0 8 _iPrinted edition:
_z9789811982507
776 0 8 _iPrinted edition:
_z9789811982514
856 4 0 _zLibro electrónico
_uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-981-19-8249-1
912 _aZDB-2-SBL
912 _aZDB-2-SXB
942 _cLIBRO_ELEC
999 _c260998
_d260997